Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1.
Saved in:
| Title: | Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1. |
|---|---|
| Authors: | Krings KS; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Hatzfeld J; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Weller S; Robert Bosch Center for Tumor Diseases Stuttgart, Stuttgart, Germany., Borkowski N; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Llewellyn TR; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Schmitt L; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Scherer B; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Itkonen HM; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Clinical Molecular Biology, EpiGen, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; EpiGen, Medical Division, Akershus University Hospital, Lørenskog, Norway., Peter C; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Stork B; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Geyh S; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Eickhoff J; Lead Discovery Center GmbH, Dortmund, Germany., Klebl B; Lead Discovery Center GmbH, Dortmund, Germany., Qin N; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany., Essmann F; Robert Bosch Center for Tumor Diseases Stuttgart, Stuttgart, Germany., Wesselborg S; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. sebastian.wesselborg@uni-duesseldorf.de.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany. sebastian.wesselborg@uni-duesseldorf.de. |
| Source: | Cell death & disease [Cell Death Dis] 2026 May 27; Vol. 17 (1). Date of Electronic Publication: 2026 May 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42204137 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Krings+KS%22">Krings KS</searchLink>; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Hatzfeld+J%22">Hatzfeld J</searchLink>; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Weller+S%22">Weller S</searchLink>; Robert Bosch Center for Tumor Diseases Stuttgart, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Borkowski+N%22">Borkowski N</searchLink>; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Llewellyn+TR%22">Llewellyn TR</searchLink>; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+L%22">Schmitt L</searchLink>; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Scherer+B%22">Scherer B</searchLink>; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Itkonen+HM%22">Itkonen HM</searchLink>; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Clinical Molecular Biology, EpiGen, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; EpiGen, Medical Division, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Peter+C%22">Peter C</searchLink>; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Stork+B%22">Stork B</searchLink>; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Geyh+S%22">Geyh S</searchLink>; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Eickhoff+J%22">Eickhoff J</searchLink>; Lead Discovery Center GmbH, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Klebl+B%22">Klebl B</searchLink>; Lead Discovery Center GmbH, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Qin+N%22">Qin N</searchLink>; Institute of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Essmann+F%22">Essmann F</searchLink>; Robert Bosch Center for Tumor Diseases Stuttgart, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Wesselborg+S%22">Wesselborg S</searchLink>; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. sebastian.wesselborg@uni-duesseldorf.de.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany. sebastian.wesselborg@uni-duesseldorf.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2026 May 27; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 May 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42204137 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41419-026-08889-6 Languages: – Code: eng Text: English Titles: – TitleFull: Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Krings KS – PersonEntity: Name: NameFull: Hatzfeld J – PersonEntity: Name: NameFull: Weller S – PersonEntity: Name: NameFull: Borkowski N – PersonEntity: Name: NameFull: Llewellyn TR – PersonEntity: Name: NameFull: Schmitt L – PersonEntity: Name: NameFull: Scherer B – PersonEntity: Name: NameFull: Itkonen HM – PersonEntity: Name: NameFull: Peter C – PersonEntity: Name: NameFull: Stork B – PersonEntity: Name: NameFull: Geyh S – PersonEntity: Name: NameFull: Eickhoff J – PersonEntity: Name: NameFull: Klebl B – PersonEntity: Name: NameFull: Qin N – PersonEntity: Name: NameFull: Essmann F – PersonEntity: Name: NameFull: Wesselborg S IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 05 Text: 2026 May 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-4889 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Cell death & disease Type: main |
| ResultId | 1 |